M S Moran

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
    Int J Radiat Oncol Biol Phys 85:40-6. 2013
  2. ncbi Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 81:1236-43. 2011
  3. ncbi ACR appropriateness criteria(®) ductal carcinoma in situ
    Meena S Moran
    Yale University School of Medicine, New Haven, USA
    Breast J 18:8-15. 2012
  4. ncbi BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility
    Ning Zhang
    Department of Breast Surgery, Qilu Hospital, Shandong University, School of Medicine, Ji Nan, PR China
    BMC Med Genet 12:48. 2011
  5. ncbi Identification of genes associated with multiple cancers via integrative analysis
    Shuangge Ma
    School of Public Health, Yale University, New Haven, CT 06520, USA
    BMC Genomics 10:535. 2009
  6. ncbi Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, 333 Cedar Street, PO Box 208040, New Haven, CT 06520 8040, USA
    Breast Cancer Res Treat 128:543-51. 2011
  7. ncbi The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
    Breast J 15:571-8. 2009
  8. ncbi Radiation techniques and toxicities for locally advanced breast cancer
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
    Semin Radiat Oncol 19:244-55. 2009
  9. ncbi Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes
    M S Moran
    Yale University School of Medicine, Department of Therapeutic Radiology, Yale New Haven Hospital, 333 Cedar Street, P O Box 208040, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 76:1026-36. 2010
  10. ncbi Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
    Cancer 113:2565-74. 2008

Detail Information

Publications16

  1. ncbi A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
    Int J Radiat Oncol Biol Phys 85:40-6. 2013
    ..This prospective, multi-institutional study was conducted to define CAM utilization in breast cancer during definitive radiation...
  2. ncbi Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 81:1236-43. 2011
    ..The purpose of our study was to assess VEGF expression in a cohort of early-stage breast cancer patients treated with BCT and to correlate the clinical and pathologic features and outcomes with overexpression of VEGF...
  3. ncbi ACR appropriateness criteria(®) ductal carcinoma in situ
    Meena S Moran
    Yale University School of Medicine, New Haven, USA
    Breast J 18:8-15. 2012
    ..In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment...
  4. ncbi BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility
    Ning Zhang
    Department of Breast Surgery, Qilu Hospital, Shandong University, School of Medicine, Ji Nan, PR China
    BMC Med Genet 12:48. 2011
    ..Furthermore, we also studied the effects of this SNP on Bcl-2 expression in vitro...
  5. ncbi Identification of genes associated with multiple cancers via integrative analysis
    Shuangge Ma
    School of Public Health, Yale University, New Haven, CT 06520, USA
    BMC Genomics 10:535. 2009
    ..A comprehensive description of the associations between genes and cancers requires identification of not only multiple genes associated with a specific type of cancer but also genes associated with multiple cancers...
  6. ncbi Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, 333 Cedar Street, PO Box 208040, New Haven, CT 06520 8040, USA
    Breast Cancer Res Treat 128:543-51. 2011
    ..The more aggressive clinical-pathologic features stage-for-stage in IP women may partially explain the more frequent use of post-mastectomy RT in this patient population. These findings warrant further investigation...
  7. ncbi The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
    Breast J 15:571-8. 2009
    ..Future investigations of chemo-preventive strategies to decrease contralateral breast cancers are warranted...
  8. ncbi Radiation techniques and toxicities for locally advanced breast cancer
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
    Semin Radiat Oncol 19:244-55. 2009
    ..This article reviews the technical aspects of radiation therapy for locally advanced breast cancer with emphasis on 3-dimensional radiotherapy techniques and discusses potential toxicities and how to reduce them...
  9. ncbi Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes
    M S Moran
    Yale University School of Medicine, Department of Therapeutic Radiology, Yale New Haven Hospital, 333 Cedar Street, P O Box 208040, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 76:1026-36. 2010
    ..We previously reported improved homogeneity with the modified segmental boost technique (MSBT) compared to that with traditional methods, using phantom models. Here we report our institutional clinical experience with MSBT...
  10. ncbi Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
    Cancer 113:2565-74. 2008
    ..African-American (AA) and white patients with early-stage disease who were treated with breast conservation therapy (BCT) were examined to detect differences in clinicopathologic features and outcomes as a function of race...
  11. ncbi Clinical implementation of prostate image guided radiation therapy: a prospective study to define the optimal field of interest and image registration technique using automated x-ray volumetric imaging software
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    Technol Cancer Res Treat 7:217-26. 2008
    ..We conclude that when utilizing the Elekta XVI automated IR software, the extended FOI/single IR results in successful registrations most often. In addition, it is currently effectively used in our clinical practice...
  12. ncbi Effects of breast-conserving therapy on lactation after pregnancy
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, Yale New Haven Hospital, New Haven, Connecticut 06520 8040, USA
    Cancer J 11:399-403. 2005
    ..Our objective was to evaluate lactation outcomes in patients with early-stage breast cancer treated with breast-conserving therapy...
  13. ncbi Improved treatment of pelvis and inguinal nodes using modified segmental boost technique: dosimetric evaluation
    Meena Moran
    Department of Therapeutic Radiology, Yale New Haven Hospital and Yale University School of Medicine, 333 Cedar Street, PO Box 208040, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 59:1523-30. 2004
    ..To describe a novel, yet simple, modified segmental boost technique (MSBT) and to compare the dosimetry of our method with that of other traditional methods of treatment for the pelvis and inguinal nodes...
  14. ncbi Management of suspicious or indeterminate calcifications and impact on local control
    Brian E Lally
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Cancer 103:2236-40. 2005
    ..CONCLUSIONS: Patients with DRC were found to have better local control than patients with NDRC. In addition, the presence of SIC on a PREMAMMO was associated with a high probability of detecting residual disease...
  15. ncbi Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation
    Bruce G Haffty
    Department of Radiation Oncology, Cancer Institute of New Jersey, Robert Wood Johnson Medical School University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08903, USA
    Int J Radiat Oncol Biol Phys 71:1006-13. 2008
    ..To evaluate the prognostic significance of cyclooxygenase-2 (COX-2) in breast cancer patients treated with conservative surgery and radiation therapy (CS+RT)...
  16. ncbi Local-regional breast cancer recurrence: prognostic groups based on patterns of failure
    Meena S Moran
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040, USA
    Breast J 8:81-7. 2002
    ..Placing patients with breast cancer and local-regional relapse into these prognostic categories may be helpful in decision making regarding the role of systemic therapy at the time of local-regional relapse...